1. The Place of GLP-1–Based Therapy in Diabetes Management: Differences Between DPP-4 Inhibitors and GLP-1 Receptor Agonists

   • Dara L. Eckerle Mize
   • Marzieh Salehi

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 12 March 2013 Pages: 307 - 318

2. Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes

   • Mary Elizabeth Cox
   • Mark N. Feinglos

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 20 March 2013 Pages: 319 - 328

3. The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus

   • Hanford Yau
   • Kathya Rivera
   • Kenneth Cusi

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) 27 April 2013 Pages: 329 - 341

   

4. Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial

   • Markolf Hanefeld
   • Peter Bramlage

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (A Vella, Section Editor) Open access 10 February 2013 Pages: 342 - 349

   

5. Is the Risk and Nature of CVD the Same in Type 1 and Type 2 Diabetes?

   • Lindsey Duca
   • Rachel Sippl
   • Janet K. Snell-Bergeon

   Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 22 March 2013 Pages: 350 - 361

   

6. Nuclear Factor (Erythroid-Derived 2)-Like-2 Factor (Nrf2), a Key Regulator of the Antioxidant Response to Protect Against Atherosclerosis and Nonalcoholic Steatohepatitis

   • Anisha A. Gupte
   • Christopher J. Lyon
   • Willa A. Hsueh

   Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 09 March 2013 Pages: 362 - 371

   

7. Exercise and Diabetes-Related Cardiovascular Disease: Systematic Review of Published Evidence from Observational Studies and Clinical Trials

   • Robert W. Koivula
   • Åsa B. Tornberg
   • Paul W. Franks

   Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 14 March 2013 Pages: 372 - 380

8. Do Statins Cause Diabetes?

   • Mark R. Goldstein
   • Luca Mascitelli

   Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 02 March 2013 Pages: 381 - 390

9. Vascular Calcification in Diabetes: Mechanisms and Implications

   • Janet K. Snell-Bergeon
   • Matthew J. Budoff
   • John E. Hokanson

   Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 24 March 2013 Pages: 391 - 402

   

10. Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction?

    • Cristina Bianchi
    • Roberto Miccoli
    • Stefano Del Prato

    Macrovascular Complications in Diabetes (PD Reaven, Section Editor) 03 March 2013 Pages: 403 - 410

    

11. Diabetes Mellitus and Osteoporosis

    • Robert Sealand
    • Christie Razavi
    • Robert A. Adler

    Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 08 March 2013 Pages: 411 - 418

12. Diabetes and HIV: Current Understanding and Future Perspectives

    • Sanjay Kalra
    • Navneet Agrawal

    Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 28 February 2013 Pages: 419 - 427

    

13. Diabetes and Infections-Hepatitis C: Is There Type 2 Diabetes Excess in Hepatitis C Infection?

    • Cho Naing
    • Joon Wah Mak
    • Mala Maung

    Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 07 March 2013 Pages: 428 - 434

    

14. Diabetes Mellitus and Inflammation

    • Eric Lontchi-Yimagou
    • Eugene Sobngwi
    • Andre Pascal Kengne

    Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 14 March 2013 Pages: 435 - 444

15. Diabetes Mellitus and Periodontal Diseases

    • Corneliu Sima
    • Michael Glogauer

    Diabetes and Other Diseases—Emerging Associations (D Aron, Section Editor) 21 February 2013 Pages: 445 - 452